Skip to main content
. 2008 Feb 11;9(4):446–457. doi: 10.1111/j.1600-0854.2008.00714.x

Figure 9. Expression of a dominant-negative SHD from Slp2-a reduces CTL-mediated killing.

Figure 9

Killing assay showing percentage lysis of targets at differing ratios of effector CTL to target in CTL expressing pmaxGFP (bold line) or the dominant-negative construct (broken line) expressing the SHD of Slp2-a tagged with pmaxGFP. Error bars show standard deviation from triplicates.